SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-012921
Filing Date
2019-05-09
Accepted
2019-05-09 18:44:51
Documents
2
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4053
2 EX-24 DOCUMENT attachment1.htm EX-24 3336
  Complete submission text file 0000899243-19-012921.txt   8787
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL ST., SUITE 101 WATERTOWN MA 02472
Business Address
Chodakewitz Jeffrey (Reporting) CIK: 0001610876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 19812281

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations